Notice of NIDA's Participation in NOT- MD-21-008 "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities"
Notice NOT-DA-22-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 26, 2021 Category: Research Source Type: funding
Check Out NIH ’s New COVID-19 Research Website
We are pleased to announce that the new NIH COVID-19 website launched last week. The site provides a central location for trusted, up-to-date, accurate information about NIH research and our strategic role in COVID-19 research. The site complements information made available on our COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage.
The new site includes information about key programs such as the Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership and the Rapid Acceleration of Diagnostics initiative to develop state-of-the-science diagnostic tests for COVID-1...
Source: NIH Extramural Nexus - January 19, 2021 Category: Research Authors: Mike Lauer Tags: blog Open Mike coronavirus COVID-19 Source Type: funding
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-078 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development, and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens, and environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologist...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-077 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood (from birth to less than 18 years of age), including the impact of pathogenic or non-pathogenic microbes or vaccination against infectious diseases, allergens or environmental pollutants on immune ontogeny and function. This program will establish collaborations among immunologists, neonatologists, pediatricians, systems biologists, and microbiologists t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 12, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
Notice of Special Interest for community-engaged research to evaluate strategies to facilitate vaccination uptake in clinical and community contexts and address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Geographic coverage: Nationwide -- National Cancer Institute, National Institute of Mental Health, National Institute on Minority Health and Health Disparities, National Institute on Minority Health and Health Disparities, National Institutes of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 22, 2020 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
Notice NOT-MD-21-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2020 Category: Research Source Type: funding
Some Thoughts Following the NIH Inclusion Across the Lifespan 2 Workshop
“The [NIH Inclusion Across the Lifespan] policy, and the review and reporting requirements associated with it, should help ensure that children and older adults are not inappropriately excluded from clinical studies. The policy also has the potential to provide a more robust understanding of the full spectrum of participants recruited into clinical studies.”
Together with my NIH colleagues Drs. Marie Bernard and Janine Clayton, we made this point in a 2018 JAMA opinion piece following the inaugural NIH Inclusion Across the Lifespan workshop. Fast forward, we revisited this issue at the NIH’s Inclusion Across the Life...
Source: NIH Extramural Nexus - December 10, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike COVID 19 Inclusion inclusion across the lifespan Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
Notice NOT-MD-21-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2020 Category: Research Source Type: funding
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
Notice NOT-AI-21-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 10, 2020 Category: Research Source Type: funding
Continued Impact of COVID-19 on Biomedical Research
It’s been over eight months since the COVID-19 pandemic crisis struck, changing every facet of life as we knew it. The U.S. biomedical research enterprise was not spared, as lockdowns and severe restrictions on activities took hold across the country. At the time, we offered our perspectives on efforts we could take to cushion the shock. Since that time, much has happened. COVID-19 research has blossomed with impressive results including FDA approval of a therapeutic agent (remdesivir, which was found to have value in a large-scale NIH-funded trial), development of several candidate vaccines that have already made to piv...
Source: NIH Extramural Nexus - November 4, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike COVID 19 Source Type: funding
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-064 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support research to advance understanding of the underlying immune mechanisms that contribute to malaria vaccine-elicited protection or vaccine hypo-responsiveness in endemic regions by capitalizing on recent research advances in systems vaccinology and systems immunology as well as emerging opportunities in data science and informatics. Multidisciplinary science and collaboration among investigators from the malaria vaccine research field and other relevant scientific areas are highly encouraged. The goal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2020 Category: Research Source Type: funding
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-060 from the NIH Guide for Grants and Contracts. This initiative will support the use of longitudinal cohorts to develop greater understanding of important elements of influenza immunity that impact vaccine response and vaccine effectiveness in older adults (those 65 and older). In addition, this work will increase our understanding of how these elements relate to severe outcomes from influenza virus infection in older adults (i.e., hospitalization and death). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 30, 2020 Category: Research Source Type: funding
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-055 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research to improve understanding of the evolutionary dynamics of seasonal influenza to increase our capacity to predict the emergence of new antigenic variants and more accurately select strains for use in the seasonal influenza vaccine. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 24, 2020 Category: Research Source Type: funding
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
Funding to develop, adapt, and test interventions to address risk factors for cancer in rural populations. Applications should focus on primary prevention and assess and address one or more of the social and behavioral risk factors that contribute to cancer disparities in rural populations: tobacco use; diet, physical activity and weight; alcohol use; UV exposure; and HPV vaccination. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - September 16, 2020 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design
Notice NOT-AI-20-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding
